Blue light filtration

Blue light filtration is not a molecule or receptor but rather a physical process or technology designed to reduce the transmission of blue wavelengths of visible light (typically 400–500 nm) to the eye. This is achieved through materials such as specialized intraocular lenses (IOLs), eyeglass coatings, or screen filters that absorb or reflect blue light. The primary rationale for blue light filtration is to protect ocular tissues—especially the retina and retinal pigment epithelium—from potential phototoxicity associated with high-energy visible (HEV) blue-violet wavelengths, which have been implicated in oxidative stress and cell damage leading to conditions like age-related macular degeneration[2][6][7]. Some studies suggest that filtering blue light may also reduce glare disability and improve visual comfort under intense lighting conditions[2][4]. However, there are concerns that excessive blocking of blue wavelengths could interfere with physiological processes such as circadian rhythm regulation—mediated by intrinsically photosensitive retinal ganglion cells sensitive to blue spectrum—and may impair low-light vision due to reduced scotopic sensitivity[4][5]. There is currently no strong clinical evidence that routine use of blue-light-filtering devices significantly improves eye health outcomes in the general population; thus, "blue light filtration" should not be considered a therapeutic target like a receptor or enzyme but rather an intervention strategy using optical materials[7]. Note: The entry "Blue light filtration" does not refer to any specific biological molecule, protein, receptor, enzyme, transporter, or gene. It describes a technological approach rather than a molecular target. Therefore: - is_target: false - is_incorrect: true — because it does not correspond to an actual molecular/therapeutic target

Other names

Blue light blockingBlue light filteringBlue-light-filtering technologyBLF (context-dependent)